The largest sputum volume was observed 3 months after OPEP device use (baseline: 10 ml, 3rd month 25 ml, p = 0.325). Additionally, Bronchiectasis Health Questionnaire score changed from 58.7 to 66.6, showing significant improvement over the treatment period ( p < 0.001). Of all enrolled patients, only two acute exacerbations occurred during the study period, indicating a significant decrease compared with the number of acute exacerbations before the device use ( p < 0.001). We evaluated the prevention of acute exacerbations, subjective symptom improvement, and change in sputum amount during the use of the Aerobika (Trudell Medical International, London, ON) OPEP device twice daily for 6 months. This open-label, single-arm, prospective study included 17 patients who experienced three or more acute exacerbations in the past year. We aimed to evaluate whether an oscillating positive expiratory pressure (OPEP) device could allow effective sputum expectoration and prevent acute exacerbations in patients with bronchiectasis who had frequent acute exacerbations. Impaired airway clearance in patients with non-cystic fibrosis bronchiectasis causes frequent bacterial infection, chronic inflammation, and progressive tissue destruction.
8Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
7Division of Pulmonary Medicine, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.6Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.5Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.4Artificial Intelligence Center, Chungbuk National University Hospital, Cheongju, Republic of Korea.3Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.2Department of Biochemistry, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.1Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.To find out if a flutter may be of help in the management of your respiratory condition, please call .uk today on 03.So Rae Kim 1,2 † Sun-Hyung Kim 3 † Geun-Hyeong Kim 4 Jun Yeun Cho 3 Hayoung Choi 5 Hyun Lee 6 Seung Won Ra 7 Ki Man Lee 3 Kang Hyeon Choe 3 Yeon-Mok Oh 8 Yoon Mi Shin 3 * ‡ Bumhee Yang 3 ‡ Chronic obstructive pulmonary disease (COPD).Some examples of conditions likely to benefit include: Can be used in combination with other respiratory physiotherapy techniquesĪny person who is suffering from a respiratory condition that involves the build up of excess phlegm would benefit from using a flutter.Flutter is compact and lightweight device that can be stored in a pocket or handbag.Other benefits of using the flutter include:
Removal of secretions significantly reduces the risk of developing a chest infection. Once the technique to use the flutter has been taught and practiced, it can be used independently by the patient at a time and place to suit them, in order to aid removal of secretions. The respiratory physiotherapists at .uk will be able to guide you in developing an effective technique to treat your specific condition. Physiotherapy is vital in establishing a technique to benefit your condition. The combination of these two effects makes the coughing up of secretions much easier.
0 kommentar(er)
